Business Context and Reporting Period
Company: Creative Medical Technology Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 1, 2016
Reporting Period: Single event date (November 1, 2016)
This filing reports a corporate governance event rather than a financial reporting period. The Company is incorporated in Nevada and maintains its principal executive offices in Phoenix, Arizona.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is a current report regarding a specific event and does not contain financial statements or performance metrics.
Material Changes
Item 8.01 - Other Events:
- The Company announced the appointment of Dr. Alexander Gershman to its Scientific Advisory Board.
- This appointment was disclosed via a press release dated November 1, 2016, which is attached as Exhibit 99.1.
Guidance, Outlook, and Risks
Forward-Looking Statements:
- The press release furnished with this filing may contain forward-looking statements based on information available as of the date made.
- Actual results could differ materially due to various factors, including those discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2015, and subsequent reports.
- The Company assumes no duty or obligation to update or revise any forward-looking statement, though it may do so as warranted or required by law.
Investor Verification Checklist
- Verify the qualifications and background of Dr. Alexander Gershman to assess the strategic value of his appointment to the Scientific Advisory Board.
- Review the full text of the press release (Exhibit 99.1) for specific details regarding Dr. Gershman's role and any associated forward-looking statements.
- Consult the Company's most recent Form 10-K (year ended December 31, 2015) and subsequent filings for comprehensive financial data and risk factors, as this 8-K does not contain them.